Connection

ANANTH ANNAPRAGADA to Drug Delivery Systems

This is a "connection" page, showing publications ANANTH ANNAPRAGADA has written about Drug Delivery Systems.
Connection Strength

0.862
  1. Non inflammatory boronate based glucose-responsive insulin delivery systems. PLoS One. 2012; 7(1):e29585.
    View in: PubMed
    Score: 0.293
  2. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release. 2005 Mar 02; 103(1):159-75.
    View in: PubMed
    Score: 0.179
  3. Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release. 2003 Nov 18; 93(1):15-28.
    View in: PubMed
    Score: 0.166
  4. Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
    View in: PubMed
    Score: 0.069
  5. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials. 2009 Aug; 30(23-24):3986-95.
    View in: PubMed
    Score: 0.061
  6. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv. 2007 Jul; 4(4):359-69.
    View in: PubMed
    Score: 0.053
  7. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 2003 Sep 19; 92(1-2):49-67.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.